Saturday, October 3, 2026

EUR/CHF Bearish Momentum: 0.91% Down In The Last 10 Sessions

ViaNews Editorial Team

October 11, 2023

EUR/CHF Bearish Momentum: 0.91% Down In The Last 10 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 0.91% for the last 10 sessions. At 04:06 EST on Wednesday, 11 October, EUR/CHF (EURCHF) is $0.96.

EUR/CHF's yearly highs and lows, it's 0.736% up from its 52-week low and 5.081% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.10%, a positive 0.04%, and a positive 0.23%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.18% (last week), 0.24% (last month), and 0.23% (last quarter), respectively.

News about

  • Eur/usd forex signal: inverted h&s pattern forms - 10 October 2023. According to DailyForex on Tuesday, 10 October, "The EUR/USD exchange rate remained in a consolidation phase as traders focused on the ongoing war in Israel and its impacts on the market. ", "Forex Brokers We Recommend in Your Region See full brokers list 1 Read full review Get Started BrokerGeoLists.push({type:'ReviewsNonPartner',id:'horizontal-top-5',size:5,fullReviewText:`Read full review`,getStartedText:`Get Started`,readReviewText:`Review`});Bullish viewBuy the EUR/USD pair and set a take-profit at 1.0650."
  • Eur/usd technical analysis: new exciting trading week - 09 October 2023. According to DailyForex on Monday, 9 October, "Expectations for the euro against the dollar today:According to the performance on the daily chart below, the price of the EUR/USD currency pair has not yet broken the general downward trend."
  • Eur/usd price analysis: seems vulnerable near mid-1.0500s amid geopolitical tensions. According to FXStreet on Monday, 9 October, "A convincing break below the said handle will reaffirm the bearish outlook and make the EUR/USD pair vulnerable to retesting the YTD low, around the 1.0450-1.0445 region touched last week. ", "The latter should act as a key pivotal point, which if cleared decisively will suggest that the EUR/USD pair has formed a near-term bottom and shift the bias in favour of bullish traders."
  • Eur/usd looking to regain high ground towards 1.06 after knocking back on gaza-fueled risk aversion. According to FXStreet on Monday, 9 October, "The Euro is seeing some twisting intraday action with hourly candles cycling the 50-hour Simple Moving Average (SMA) that is rising into 1.0550, and the EUR/USD is currently testing 1.0565, down a scant 0.08% from the day's highs set early in the day at the market open.", "The EUR/USD is testing upwards into 1.0570 after slipping down into 1.0520 to kick off the trading week. "
  • Eur/usd trades higher around 1.0570 amid palestine-Israel military conflict. According to FXStreet on Monday, 9 October, "The renewed geopolitical tensions could impact the recent surge of the EUR/USD pair. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com